FTC sues to block Amgen’s acquisition of Horizon Therapeutics By: MarketWatch May 16, 2023 at 13:44 PM EDT Deal could allow Amgen to "entrench the monopoly positions" of two Horizon medications, regulators say. Read More >> Related Stocks: Amgen Horizon Therapeutics Merck & Co Pfizer Prometheus Biosciences Inc Seagen Inc
